These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

814 related items for PubMed ID: 8826940

  • 1. Flow cytometric DNA analysis of cirrhotic liver cells in patients with hepatocellular carcinoma can provide a new prognostic factor.
    Ruà S, Comino A, Fruttero A, Torchio P, Bouzari H, Taraglio S, Torchio B, Capussotti L.
    Cancer; 1996 Sep 15; 78(6):1195-202. PubMed ID: 8826940
    [Abstract] [Full Text] [Related]

  • 2. Survival after liver transplantation in cirrhotic patients with and without hepatocellular carcinoma: a comparative study.
    Figueras J, Jaurrieta E, Valls C, Benasco C, Rafecas A, Xiol X, Fabregat J, Casanovas T, Torras J, Baliellas C, Ibañez L, Moreno P, Casais L.
    Hepatology; 1997 Jun 15; 25(6):1485-9. PubMed ID: 9185772
    [Abstract] [Full Text] [Related]

  • 3. Reevaluation of prognostic factors for survival after liver resection in patients with hepatocellular carcinoma in a Japanese nationwide survey.
    Ikai I, Arii S, Kojiro M, Ichida T, Makuuchi M, Matsuyama Y, Nakanuma Y, Okita K, Omata M, Takayasu K, Yamaoka Y.
    Cancer; 2004 Aug 15; 101(4):796-802. PubMed ID: 15305412
    [Abstract] [Full Text] [Related]

  • 4. Flow cytometric DNA analysis of hepatocellular carcinoma: preliminary report.
    Chen MF, Hwang TL, Tsao KC, Sun CF, Chen TJ.
    Surgery; 1991 Apr 15; 109(4):455-8. PubMed ID: 1706892
    [Abstract] [Full Text] [Related]

  • 5. Usefulness of tumor pressure as a prognostic factor in cases of hepatocellular carcinoma where the diameter of the tumor is 3 cm or less.
    Ueki T, Sakaguchi S, Miyajima Y, Hatono N, Tohara K, Nakabayashi S, Yao T, Kokawa H, Hirano M, Okumura M.
    Cancer; 2002 Aug 01; 95(3):596-604. PubMed ID: 12209753
    [Abstract] [Full Text] [Related]

  • 6. Nodules less than 20 mm and vascular invasion are predictors of survival in small hepatocellular carcinoma.
    Kikuchi LO, Paranaguá-Vezozzo DC, Chagas AL, Mello ES, Alves VA, Farias AQ, Pietrobon R, Carrilho FJ.
    J Clin Gastroenterol; 2009 Feb 01; 43(2):191-5. PubMed ID: 19142170
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Prognostic significance of DNA ploidy and proliferation in 309 colorectal carcinomas as determined by two-color multiparametric DNA flow cytometry.
    Zarbo RJ, Nakhleh RE, Brown RD, Kubus JJ, Ma CK, Mackowiak P.
    Cancer; 1997 Jun 01; 79(11):2073-86. PubMed ID: 9179053
    [Abstract] [Full Text] [Related]

  • 9. How should patients with hepatocellular carcinoma be staged? Validation of a new prognostic system.
    Farinati F, Rinaldi M, Gianni S, Naccarato R.
    Cancer; 2000 Dec 01; 89(11):2266-73. PubMed ID: 11147597
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [Prognostic factors of hepatocellular carcinoma after liver transplantation].
    Zhou LX, Yan LN.
    Ai Zheng; 2006 Jun 01; 25(6):736-9. PubMed ID: 16764771
    [Abstract] [Full Text] [Related]

  • 12. A DNA cytometric proliferation index improves the value of the DNA ploidy pattern as a prognosticating tool in patients with carcinoma of the prostate.
    Ahlgren G, Lindholm K, Falkmer U, Abrahamsson PA.
    Urology; 1997 Sep 01; 50(3):379-84. PubMed ID: 9301701
    [Abstract] [Full Text] [Related]

  • 13. Factors correlated with portal venous invasion by hepatocellular carcinoma: univariate and multivariate analyses of 232 resected cases without preoperative treatments.
    Adachi E, Maeda T, Kajiyama K, Kinukawa N, Matsumata T, Sugimachi K, Tsuneyoshi M.
    Cancer; 1996 May 15; 77(10):2022-31. PubMed ID: 8640665
    [Abstract] [Full Text] [Related]

  • 14. Prognostic value of S-phase fraction in lymph-node-negative breast cancer by image and flow cytometric analysis.
    Peiró G, Lerma E, Climent MA, Seguí MA, Alonso MC, Prat J.
    Mod Pathol; 1997 Mar 15; 10(3):216-22. PubMed ID: 9071729
    [Abstract] [Full Text] [Related]

  • 15. Cell proliferation in renal cell carcinoma. A clinical study with special reference to prognosis.
    Larsson P.
    Scand J Urol Nephrol Suppl; 1994 Mar 15; 165():1-48. PubMed ID: 7871395
    [Abstract] [Full Text] [Related]

  • 16. Hepatocyte proliferation and risk of hepatocellular carcinoma in cirrhotic patients.
    Sangiovanni A, Colombo E, Radaelli F, Bortoli A, Bovo G, Casiraghi MA, Ceriani R, Roffi L, Redaelli A, Rossini A, Spinzi G, Minoli G.
    Am J Gastroenterol; 2001 May 15; 96(5):1575-80. PubMed ID: 11374702
    [Abstract] [Full Text] [Related]

  • 17. Microvascular invasion in patients with hepatocellular carcinoma and its predictable clinicopathological factors.
    Sumie S, Kuromatsu R, Okuda K, Ando E, Takata A, Fukushima N, Watanabe Y, Kojiro M, Sata M.
    Ann Surg Oncol; 2008 May 15; 15(5):1375-82. PubMed ID: 18324443
    [Abstract] [Full Text] [Related]

  • 18. Flow cytometric evaluation of early invasive cervical cancer.
    Connor JP, Miller DS, Bauer KD, Murad TM, Rademaker AW, Lurain JR.
    Obstet Gynecol; 1993 Mar 15; 81(3):367-71. PubMed ID: 8437788
    [Abstract] [Full Text] [Related]

  • 19. Prognostic values of alpha-fetoprotein and protein induced by vitamin K absence or antagonist-II in hepatitis B virus-related hepatocellular carcinoma: a prospective study.
    Kim HS, Park JW, Jang JS, Kim HJ, Shin WG, Kim KH, Lee JH, Kim HY, Jang MK.
    J Clin Gastroenterol; 2009 Mar 15; 43(5):482-8. PubMed ID: 19197197
    [Abstract] [Full Text] [Related]

  • 20. [Analysis of the risk factors influencing the prognosis of orthotopic liver transplantation for hepatocellular carcinoma and summary of relevant clinical experience].
    He YF, Fan J, Zhou J, Wu ZQ, Qiu SJ, Huang XW, Yu Y, Sun J, Xiao YS, Yang GH, Song K, Wang Z, Tang ZY, Wang YQ.
    Zhonghua Yi Xue Za Zhi; 2006 May 16; 86(18):1232-5. PubMed ID: 16796877
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 41.